Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation ...
Heavy ligands such as polyoxometalates are opening a new frontier in actinide chemistry. Studying materials that are both ...
Curium Pharma (“Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products Co. (Monrol), a leading nuclear medicine ...
Curium Pharma has completed its acquisition of Eczacıbaşı-Monrol Nuclear Products Co., enhancing its capacity in nuclear ...